Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

TNFAIP8 polarity proteins mediate T cell development by propagating lipid second messenger signaling in thymocytes.

Created on 18 Nov 2026

Authors

Jingtao Gao, Cun Guo, Yang Lv, Han Wang, Sheng Chen, Peili Zhuang, Miaomiao Song, Xueqin Tian, Shan Jiang, Wei Lu, Lu Zhang, Peiqing Zhao, Xiaohan Wu, Xiangfeng Song, Xiaohong Kang, Youhai H Chen, Tingmin Chang, Hui Wang, Yunwei Lou

Published in

Cell death & disease. Volume 17. Issue 1. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

T lymphocytes are primarily generated in the thymus through a complex process of positive and negative selections. The molecular mechanisms underlying this process are not fully understood. Here, we report that TNFAIP8 (TNF-α-induced protein 8-like) family of polarity proteins mediates T cell development by propagating phosphoinositide signaling in the thymus. Genetic deletion of hematopoietic members of the TNFAIP8 family resulted in dramatic reductions in thymus size, cellularity, and corticomedullary differentiation. Total thymocyte counts in Tnfaip8-deficient mice were reduced by more than 50%, which was associated with marked reductions in T cell numbers in blood and in secondary lymphoid organs, as compared to wild-type mice. Bone marrow chimeric experiments revealed that the thymic developmental defect was hematopoietic cell-intrinsic. TNFAIP8 proteins controlled double negative (DN) thymocyte proliferation and metabolism during positive selection by promoting PI3K-AKT/mTOR signaling through phosphoinositide second messengers. Pharmaceutical activation of AKT partially rectified the thymic developmental defect of Tnfaip8-deficient mice. Thus, TNFAIP8 polarity proteins are essential for thymic development of T lymphocytes, and genetic or pharmaceutical manipulation of the TNFAIP8 pathway may be useful for controlling T lymphocyte-mediated immunity.

PMID:
42907424
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement